logo
Select company
Select metric
$ 41.15MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
13
Sector
18
Industry
6
History
27
$ 4.08Close
$ 1.96 - $ 4.24 52-Week Range
Ticker Information

Ticker

IMDX

Company Name

INSIGHT MOLECULAR DIAGNOSTICS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

INSIGHT MOLECULAR DIAGNOSTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMDX - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 41.15M
3/31/2025$ 56.96M
12/31/2024$ 27.81M
9/30/2024$ 15.82M
6/30/2024$ 15.81M
3/31/2024$ 13.85M
12/31/2023$ 13.85M
9/30/2023$ 13.85M
6/30/2023$ 13.85M
3/31/2023$ 32.81M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INSIGHT MOLECULAR DIAGNOSTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 27M.
  • Over the past 5 years, INSIGHT MOLECULAR DIAGNOSTICS INC's average CF - Equity has been $ 37.39M.
  • The median CF - Equity for INSIGHT MOLECULAR DIAGNOSTICS INC during this period was $ 30.31M
  • INSIGHT MOLECULAR DIAGNOSTICS INC reached its highest CF - Equity over the past 5 years at $ 87.82M.
  • The lowest CF - Equity recorded by INSIGHT MOLECULAR DIAGNOSTICS INC in the same timeframe $ 9.83M

INSIGHT MOLECULAR DIAGNOSTICS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
VNRX : VOLITIONRX LTD $ 10.43MARMP : ARMATA PHARMACEUTICALS INC $ 0CBUS : CIBUS INC $ 0PYXS : PYXIS ONCOLOGY INC $ 1.71MNTRB : NUTRIBAND INC $ 5.21MPRPH : PROPHASE LABS INC $ 6.53MLUCD : LUCID DIAGNOSTICS INC $ 31.62MPSTV : PLUS THERAPEUTICS INC $ 17.8MBNBX : APPLIED DNA SCIENCES INC $ 7.54MALGS : ALIGOS THERAPEUTICS INC $ 101.71M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

IMDX - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 9.83M

Minimum

Mar 31, 2022

$ 87.82M

Maximum

Mar 31, 2021

$ 37.39M

Average

$ 30.31M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 98.02K with a standard deviation of $ 17.64M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 98.02K
median$ 0
std$ 17.64M